> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Harvard, DARPA Screening FDA Covid Drug Effectiveness
- URL: https://www.fdaweb.com/harvard-darpa-screening-fda-covid-drug-effectiveness/
- Published: 2020-06-18T12:00:00.000Z
- Updated: 2026-09-14T16:18:42.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147043

A $16 million partnership between the Defense Advanced Research Projects Agency and Harvard University is aimed at narrowing down which medication, approved by FDA, is effective for treating Covid-19 patients. The UK’s *International Business Times* [reports](https://www.ibtimes.co.uk/harvard-darpa-collaborate-16-mn-deal-screen-fda-approved-covid-19-drugs-1679675?ref=fdaweb.com) the collaboration is working “with the help of cutting-edge computational drug discovery pipelines and human organ chip technology.”

The article says the method allows researchers to test and analyze human response to Covid-19 infections and to verify if a specific drug is effective as a treatment. Researchers at Mount Sinai’s School of Medicine and the University of Maryland also are helping with parallel experiments to determine which work and those that do not, it says.